Overview
Lenmid 25 mg contains Lenalidomide, a thalidomide analog used as part of chemotherapy regimens for certain blood cancers, particularly multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. Lenalidomide works by modifying immune responses, inhibiting the growth of abnormal cells, and restricting blood supply to tumors. The 25 mg strength is commonly used during induction or active phases of treatment under close medical supervision.



